Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, T-Cell 1

Interventions

fludarabine 2Cyclophosphamide 2pegylated granulocyte colony-stimulating factor, human 1pegfilgrastim 1pegaspargase 1dexamethasone acetate 1Tetrahydrouridine 1Surveys and Questionnaires 1Sugars 1Melphalan 1Loratadine 1Lenalidomide 1Decitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Lymphoma, T-Cell × pegaspargase × Clear all
NCT01878708 2017-03-06

A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma

Dana-Farber Cancer Institute

Phase EARLY_PHASE1 Terminated
2 enrolled
Lymphoid

Lymphoma, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡